23 May 2013
Keywords: elixir, licenses, myolimus, novartis, firm, medical, entered
Article | 20 October 2008
US firm Elixir Medical has entered into a co-exclusive worldwide license agreement with Swiss drug major Novartis for the rights ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
22 May 2013
© 2013 thepharmaletter.com